SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14C - Other definitive information statements:
SEC Accession No. 0000950123-10-046920
Filing Date
2010-05-10
Accepted
2010-05-10 11:38:42
Documents
1
Period of Report
2010-05-10
Effectiveness Date
2010-05-10

Document Format Files

Seq Description Document Type Size
1 DEF 14C w78317adef14c.htm DEF 14C 95983
  Complete submission text file 0000950123-10-046920.txt   97563
Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14C | Act: 34 | File No.: 001-15070 | Film No.: 10814893
SIC: 2834 Pharmaceutical Preparations